161 Development of a CD8 co-receptor independent T cell receptor specific for tumor-associated antigen MAGE-A4 for next generation T cell-based immunotherapy

Similar Items

• Development of a CD8 co-receptor independent T-cell receptor specific for tumor-associated antigen MAGE-A4 for next generation T-cell-based immunotherapy
  by: Daniel Sommermeyer, et al.
  Published: (2021-03-01)
• Inhibitory CD161 receptor identified in glioma-infiltrating T cells by single-cell analysis
  Published: (2022)
• Preclinical evaluation of an affinity-enhanced MAGE-A4-specific T-cell receptor for adoptive T-cell therapy
  by: Joseph P Sanderson, et al.
  Published: (2020-01-01)
• MAGE-A1 in lung adenocarcinoma as a promising target of chimeric antigen receptor T cells
  by: Yuan Mao, et al.
  Published: (2019-10-01)
• Affinity-enhanced T-cell receptors for adoptive T-cell therapy targeting MAGE-A10: strategy for selection of an optimal candidate
  by: Ellen C. Border, et al.
  Published: (2019-02-01)